WHITEHAWK THERAPEUTICS, INC. (WHWK) Operating cash flow 2016–2025
WHITEHAWK THERAPEUTICS, INC. (WHWK) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$97.4MFY2025 · since FY2016: -$24,517 → -$97.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$97.4M | -63.6% |
| FY2024 | -$59.5M | +0.2% |
| FY2023 | -$59.7M | -20.2% |
| FY2022 | -$49.6M | -121.4% |
| FY2021 | -$22.4M | -76.5% |
| FY2020 | -$12.7M | +46.8% |
| FY2019 | -$23.9M | -310.7% |
| FY2018 | -$5.8M | +69.2% |
| FY2017 | -$18.9M | -76922.2% |
| FY2016 | -$24,517 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More WHWK financial trends
WHWK RevenueWHWK Net incomeWHWK Net marginWHWK Gross profitWHWK Gross marginWHWK Operating incomeWHWK Operating marginWHWK Free cash flowWHWK Capital expendituresWHWK Return on equityWHWK Stock buybacksWHWK Dividends paidWHWK Total assetsWHWK Total liabilitiesWHWK Shareholders’ equityWHWK overview →